ACTIVE

REYNDERS PHARMACEUTICAL LABELS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

9,2 M €

-7.7% YoY

Revenue

42,4 M €

+0.3% YoY

Equity

15,1 M €

+26.8% YoY

Workforce

130,0 ETP

+6.7% YoY

What does REYNDERS PHARMACEUTICAL LABELS do?

REYNDERS PHARMACEUTICAL LABELS is a Public limited company incorporated in 1991. Its main activity is: Manufacture of articles of paper and paperboard. Its registered office is in Boechout. It employs on average 130,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0443.025.922

Incorporation

15/01/1991

Legal form

Public limited company

Registered office

Nijverheidsstraat 15
2530 Boechout · FlandreSee on map

Contributed capital

375 000,00 €

Latest accounts

31/12/2025

Average workforce

130,0 ETP

Activities (NACE)

17250Manufacture of articles of paper and paperboard· main 17290Manufacture of other articles of paper and paperboard 18120Other printing 18120Other printing 21250Manufacture of pharmaceutical preparations 22220Manufacture of plastic packing goods

Joint committees (5)

130
1300
200
2000
218

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	42,4 M €	+0.3%	42,2 M €	+7.7%	39,2 M €	+6.5%	36,8 M €	+20.9%	30,5 M €	+26.7%	24 M €	+3.1%	23,3 M €	+4.2%	22,4 M €	+1.5%	22 M €	+8.0%	20,4 M €	+1.0%	20,2 M €	-2.3%	20,7 M €	+8.8%	19 M €	+11.7%	17 M €	+9.9%	15,5 M €	-0.0%	15,5 M €	+3.6%	14,9 M €	+5.2%	14,2 M €
EBITDA	13,3 M €	-5.6%	14,1 M €	+8.8%	12,9 M €	+2.3%	12,6 M €	+29.9%	9,7 M €	+37.0%	7,1 M €	+3.3%	6,9 M €	+10.5%	6,2 M €	+6.8%	5,8 M €	+7.9%	5,4 M €	+7.3%	5 M €	+19.1%	4,2 M €	+56.9%	2,7 M €	-3.1%	2,8 M €	+13.9%	2,4 M €	-5.4%	2,6 M €	-13.7%	3 M €	-2.1%	3,1 M €
Operating result	12 M €	-7.6%	13 M €	+3.0%	12,7 M €	+17.4%	10,8 M €	+23.2%	8,8 M €	+54.1%	5,7 M €	-2.7%	5,8 M €	+14.5%	5,1 M €	+6.5%	4,8 M €	+11.2%	4,3 M €	+6.3%	4 M €	+25.8%	3,2 M €	+63.4%	2 M €	-8.8%	2,2 M €	+47.5%	1,5 M €	+21.3%	1,2 M €	-21.9%	1,5 M €	-4.6%	1,6 M €
Net result	9,2 M €	-7.7%	10 M €	+2.3%	9,7 M €	+14.9%	8,5 M €	+25.2%	6,8 M €	+62.4%	4,2 M €	+3.8%	4 M €	+18.1%	3,4 M €	+0.8%	3,4 M €	+10.7%	3 M €	+7.3%	2,8 M €	+22.8%	2,3 M €	+28.1%	1,8 M €	+14.9%	1,6 M €	+40.5%	1,1 M €	+14.2%	978,4 k €	-22.9%	1,3 M €	-3.1%	1,3 M €
Balance sheet
Equity	15,1 M €	+26.8%	11,9 M €	+40.5%	8,5 M €	-60.4%	21,4 M €	+31.8%	16,2 M €	+45.0%	11,2 M €	+10.9%	10,1 M €	+11.0%	9,1 M €	+7.4%	8,5 M €	+4.0%	8,1 M €	+2.7%	7,9 M €	+7.3%	7,4 M €	+7.4%	6,9 M €	+3.7%	6,6 M €	+7.4%	6,2 M €	+22.1%	5,1 M €	+0.1%	5,1 M €	+0.2%	5 M €
Total assets	28,4 M €	+0.2%	28,3 M €	+12.5%	25,2 M €	-1.8%	25,6 M €	+27.7%	20,1 M €	+45.6%	13,8 M €	+0.8%	13,7 M €	+6.7%	12,8 M €	+15.8%	11,1 M €	+2.5%	10,8 M €	+5.0%	10,3 M €	+5.3%	9,8 M €	-2.8%	10,1 M €	+16.6%	8,6 M €	+13.0%	7,6 M €	+2.7%	7,4 M €	-5.6%	7,9 M €	+3.9%	7,6 M €
Cash	11,1 M €	+4.4%	10,6 M €	+27.3%	8,3 M €	-11.1%	9,4 M €	+32.1%	7,1 M €	+17.8%	6 M €	-0.3%	6,1 M €	+24.2%	4,9 M €	+59.1%	3,1 M €	-11.7%	3,5 M €	-28.8%	4,9 M €	+43.4%	3,4 M €	+96.7%	1,7 M €	-31.3%	2,5 M €	+46.9%	1,7 M €	-33.0%	2,6 M €	+73.2%	1,5 M €	+67.3%	881,9 k €
Debts	12,5 M €	-20.4%	15,7 M €	-0.7%	15,8 M €	+364%	3,4 M €	+1.4%	3,4 M €	+62.8%	2,1 M €	-13.2%	2,4 M €	+2.1%	2,3 M €	+28.5%	1,8 M €	-5.0%	1,9 M €	+19.9%	1,6 M €	-4.1%	1,7 M €	-32.7%	2,5 M €	+79.3%	1,4 M €	+53.0%	897,8 k €	-53.0%	1,9 M €	-21.8%	2,4 M €	+9.8%	2,2 M €
Other
Workforce	130,0 ETP	+6.7%	121,8 ETP	+3.0%	118,2 ETP	+4.1%	113,5 ETP	+6.1%	107,0 ETP	+8.3%	98,8 ETP	+7.7%	91,7 ETP	+6.4%	86,2 ETP	+4.0%	82,9 ETP	-1.0%	83,7 ETP	+1.9%	82,1 ETP	+2.0%	80,5 ETP	+2.7%	78,4 ETP	+15.1%	68,1 ETP	-3.9%	70,9 ETP	-1.4%	71,9 ETP	-3.6%	74,6 ETP	+9.7%	68,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 41 ended

Active mandates

LINTACKER CONSULTING

Director · since 10 juillet 2020 · until 20 avril 2026 · 0861.171.245

Represented by Jacques Reynders

Active

REYNESCO INVEST

Managing director · since 10 juillet 2020 · until 20 avril 2026 · 0554.769.625

Represented by Marc REYNDERS

Active

Ended mandates

LINTACKER CONSULTING

Director · since 10 juillet 2020 · until 15 mai 2026 · 0861.171.245

Represented by Jacques Reynders

Ended

LINTACKER CONSULTING

Director · since 10 juillet 2020 · until 15 mai 2026 · 0861.171.245

Represented by Jacques REYNDERS

Ended

MRS CONSULTING

Director · since 10 juillet 2020 · until 15 mai 2026 · 0861.171.146

Represented by Sebastiaan Reynders

Ended

MRS CONSULTING

Director · since 10 juillet 2020 · until 01 octobre 2021 · 0861.171.146

Represented by Sebastiaan REYNDERS

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/05/2026	23/04/2025	22/04/2024	05/07/2023	15/06/2022	14/06/2021
General meeting	20/04/2026	22/04/2025	22/04/2024	20/05/2023	20/05/2022	15/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	20/04/2026	19/05/2026	Dutch	PDF
Full model	31/12/2024	22/04/2025	23/04/2025	Dutch	PDF
Full model	31/12/2023	22/04/2024	22/04/2024	Dutch	PDF
Full model	31/12/2022	20/05/2023	05/07/2023	Dutch	PDF
Full model	31/12/2021	20/05/2022	15/06/2022	Dutch	PDF
Full model	31/12/2020	15/05/2021	14/06/2021	Dutch	PDF
Full model	31/12/2019	01/06/2020	30/06/2020	Dutch	PDF
Full model	31/12/2018	15/05/2019	14/06/2019	Dutch	PDF
Full model	31/12/2017	15/05/2018	25/06/2018	Dutch	PDF
Full model	31/12/2016	15/05/2017	14/06/2017	Dutch	PDF
Full model	31/12/2015	16/05/2016	02/06/2016	Dutch	PDF
Full model	31/12/2014	15/05/2015	19/05/2015	Dutch	PDF
Full model	31/12/2013	15/05/2014	20/05/2014	Dutch	PDF
Full model	31/12/2012	15/05/2013	23/05/2013	Dutch	PDF
Full model	31/12/2011	15/05/2012	05/06/2012	Dutch	PDF
Full model	31/12/2010	15/05/2011	31/05/2011	Dutch	PDF
Full model	31/12/2009	15/05/2010	19/05/2010	Dutch	PDF
Full model	31/12/2008	15/05/2009	09/06/2009	Dutch	PDF
Full model	31/12/2007	15/05/2008	09/06/2008	Dutch	PDF
Full model	31/12/2006	15/05/2007	15/05/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 41 ended

Active mandates

LINTACKER CONSULTING

Director · since 10 juillet 2020 · until 20 avril 2026 · 0861.171.245

Represented by Jacques Reynders

Active

REYNESCO INVEST

Managing director · since 10 juillet 2020 · until 20 avril 2026 · 0554.769.625

Represented by Marc REYNDERS

Active

Ended mandates

LINTACKER CONSULTING

Director · since 10 juillet 2020 · until 15 mai 2026 · 0861.171.245

Represented by Jacques Reynders

Ended

LINTACKER CONSULTING

Director · since 10 juillet 2020 · until 15 mai 2026 · 0861.171.245

Represented by Jacques REYNDERS

Ended

MRS CONSULTING

Director · since 10 juillet 2020 · until 15 mai 2026 · 0861.171.146

Represented by Sebastiaan Reynders

Ended

MRS CONSULTING

Director · since 10 juillet 2020 · until 01 octobre 2021 · 0861.171.146

Represented by Sebastiaan REYNDERS

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates11/06/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other04/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN - DOEL - ALGEMENE VERGADERING
PDF
Mandates19/09/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/10/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/07/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/02/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates01/07/2019
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20259,2 M €↓
2024
Annual accounts 202410 M €↑
2023
Annual accounts 20239,7 M €↑
2022
Annual accounts 20228,5 M €↑
2021
Annual accounts 20216,8 M €↑
2018
Annual accounts 20184,2 M €↑
2017
Annual accounts 20174 M €↑
2016
Annual accounts 20163,4 M €↑
2015
Annual accounts 20153,4 M €↑
2014
Annual accounts 20143 M €↑
2013
Annual accounts 20132,8 M €↑
2012
Annual accounts 20122,3 M €↑
2011
Annual accounts 20111,8 M €↑
2010
Annual accounts 20101,6 M €↑
2009
Annual accounts 20091,1 M €↑
2008
Annual accounts 2008978,4 k €↓
2007
Annual accounts 20071,3 M €↓
2006
Annual accounts 20061,3 M €
15/01/1991
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

REYNDERS PHARMACEUTICAL LABELS

Overview

What does REYNDERS PHARMACEUTICAL LABELS do?

Trend over 18 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline